Pharmaron Beijing Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 2,626.486 million compared to CNY 2,035.503 million a year ago. Operating income was CNY 367.820 million compared to CNY 259.939 million a year ago. Net income was CNY 328.380 million compared to CNY 224.536 million a year ago. Basic earnings per share from continuing operations was CNY 0.506 compared to CNY 0.3801 a year ago.